Prognosis
Novavax Covid Vaccine Gets $1.6 Billion in U.S. Funding
- Backing is biggest so far in Operation Warp Speed program
- Novavax and pharmaceutical giants race to develop a shot
This article is for subscribers only.
Novavax Inc., one of the front-runners in the race to develop a Covid-19 vaccine, will receive $1.6 billion from the U.S. government, the biggest contribution yet from the Operation Warp Speed program.
The funds will allow the company to conduct advanced human studies and establish manufacturing to deliver 100 million doses as soon as late 2020, Gaithersburg, Maryland-based Novavax said in a statement.